Local view for "http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/DB05039"

PredicateValue (sorted: none)
drugbank:interactsWith
owl:sameAs
drugbank:interactsWith
drugbank:interactsWith
owl:sameAs
drugbank:interactsWith
drugbank:interactsWith
owl:sameAs
owl:sameAs
drugbank:interactsWith
drugbank:interactsWith
owl:sameAs
owl:sameAs
owl:sameAs
drugbank:interactsWith
owl:sameAs
owl:sameAs
drugbank:interactsWith
owl:sameAs
drugbank:interactsWith
owl:sameAs
rdf:type
drugbank:interactsWith
owl:sameAs
owl:sameAs
owl:sameAs
drugbank:interactsWith
owl:sameAs
drugbank:interactsWith
owl:sameAs
owl:sameAs
drugbank:interactsWith
drugbank:interactsWith
drugbank:interactsWith
drugbank:interactsWith
rdfs:label
"Indacaterol"
drugbank:interactsWith
drugbank:interactsWith
drugbank:interactsWith
owl:sameAs
owl:sameAs
drugbank:interactsWith
owl:sameAs
drugbank:description
"Indacaterol is a novel, ultra-long-acting, rapid onset β(2)-adrenoceptor agonist developed for Novartis for the once-daily management of asthma and chronic obstructive pulmonary disease. It was approved by the European Medicines Agency (EMA) under the trade name Onbrez on November 30, 2009, and by the United States Food and Drug Administration (FDA), under the trade name Arcapta Neohaler, on July 1, 2011. Indacaterol is provided as its maleate salt form. Indacaterol is also a chiral molecule but only the pure R-enantiomer is dispensed. "
owl:sameAs
owl:sameAs
owl:sameAs
owl:sameAs
owl:sameAs
drugbank:interactsWith
drugbank:interactsWith
drugbank:interactsWith
owl:sameAs
owl:sameAs
owl:sameAs
drugbank:interactsWith

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines3/drugbank_small.nt

The resource appears as object in 51 triples

Context graph